Company Product Description Indication Status
Roche Group, of Basel Switzerland Cobas SARS-CoV-2 & Influenza A/B Test Multiplex reverse transcription polymerase chain reaction assay; runs on the Cobas 6800/8800 systems For the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A and influenza B Received emergency use authorization from the U.S. FDA

Notes

For more information about individual companies and/or products, see Cortellis.